Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline
Helpline
Call 1.855.378.4373 to schedule a call time with a specialist

The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

A new report from KFF Health News shows for the first time how much local governments are receiving from opioid settlements, revealing large differences among localities.
A coalition of criminal justice reform groups is urging the federal government to reconsider the Food and Drug Administration’s proposed ban on flavored tobacco products, The Hill reports. The groups warn the ban would lead to more overpolicing in communities of color.
New recommendations by an expert panel call for routine screening of adults ages 19 to 64 for anxiety disorders, CNN reports.
Find more of our must-reads in policy news, including documents made public that reveal the opioid settlement amounts paid to localities.
View our curated digest of the latest research news, including a review of multidisciplinary strategies for preventing opioid use and escalation by targeting mental health symptoms and conditions for youth at high risk.
Federal health officials say more research is needed to maximize the use of fentanyl test strips, STAT reports.
A new study finds just one-fourth of residential addiction treatment facilities that serve teens offers buprenorphine to treat opioid use disorder, STAT reports.
Almost 15% of U.S. children were treated for mental health disorders in 2021, according to new data from the Centers for Disease Control and Prevention.
Find more of our must-reads in policy news, including federal officials' call to expand access to and research on fentanyl test strips.
View our curated digest of the latest research news, including the association between nicotine vaping and other substance use among adolescents.
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration, published national model standards for substance use, mental health and family peer worker certifications on Tuesday.
Indivior, the maker of the medication for opioid use disorder Suboxone, settled with multiple states and the District of Columbia for $102.5 million over its alleged anticompetitive practices, the Washington Post reports. 
A new study found that over 80% of people in New York City who use substances tested positive for fentanyl, even though only 18% used it intentionally.
Find more of our must-reads in policy news, including SAMHSA publishing their National Model Standards for Peer Support Certification.
View our curated digest of the latest research news, including the association between nicotine vaping and other substance use among adolescents in the United States.
A growing number of experts are calling for changes to laws that criminalize substance use in pregnancy, NBC News reports.
A federal court on Tuesday approved a plan for Purdue Pharma, maker of OxyContin, to settle thousands of legal claims related to the opioid crisis.
A proposed bipartisan measure would make fentanyl trafficking a national security threat, The Hill reports.
Find more of our must-reads in policy news, including a federal appeals court clearing the way for a Purdue settlement that protects the Sackler family from future lawsuits.
View our curated digest of the latest research news, including language considerations for children of parents with substance use disorders.
A new report by the U.S. Surgeon General warns that social media poses a “profound risk of harm” to the mental health of children and teens, The New York Times reports.
A new study finds the use of methadone among Medicare patients to treat opioid use disorder rose sharply after the program began covering the treatment.
The Food and Drug Administration this week approved a new nasal spray to reverse opioid overdoses, the Associated Press reports.
Find more of our must-reads in policy news, including the FDA approving a nalmefene nasal spray to reverse opioid overdoses.
View our curated digest of the latest research news, including a study on patterns of tobacco product use and substance misuse among adolescents in the United States.
1 6 7 8 9 10 358